H R Hygiene Products Limited has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI), marking a significant step towards its public listing on the SME platform. Based in Rajkot, Gujarat, the company manufactures hygiene products across four brand verticals — Femiss, Womanica, ElderFit, and Bloom Baby. The IPO aims to raise capital for setting up a new manufacturing facility and repaying debt, signaling a strategic expansion into the diaper market.

Company Overview

H R Hygiene Products Limited is a Gujarat-based manufacturer established in 2016. The company operates under four distinct brands catering to babies, young women, and the elderly. Its core revenue driver is sanitary napkins, which contributed 95.33% of revenue in Fiscal 2026. The company holds ISO 9001:2015, WHO-GMP, and BIS certifications.

The firm employs a dual-channel distribution strategy, leveraging offline networks with 25 Consignment Sales Agents (CSAs) and approximately 202 distributors across 28 states and 8 union territories, alongside online presence on platforms like Meesho, Amazon, and Flipkart. The Femiss Sanitary Pad received the National Award for Excellence in Healthcare 2020 for 'Best Emerging Brand of the Year'.

Offer Details

The IPO is structured as a Fresh Issue. Specific price band, face value, and lot size details are not yet available. The identified use of proceeds totals ₹34.93 Crore, excluding general corporate purposes.

Objects of Issue

Financial Highlights

The company has demonstrated strong growth in revenue and profitability over the last three fiscal years. Revenue from operations grew from ₹84.35 Crore in FY2024 to ₹130.72 Crore in FY2026. Net Profit (PAT) improved from ₹4.66 Crore in FY2024 to ₹11.41 Crore in FY2026.

Key Ratios

Risk Factors

Investors should note several material risks highlighted in the DRHP:

1. Product Concentration: Sanitary napkins account for 95.33% of revenue in Fiscal 2026, exposing the company to product-specific demand shocks.
2. Customer Concentration: Top 10 customers contribute 80.41% of revenue in Fiscal 2026, with no long-term contracts in place.
3. Geographic Concentration: 77.02% of revenue is derived from Gujarat in Fiscal 2026.
4. Cash Flow Volatility: The company reported negative operating cash flow of ₹10.08 Crore in FY2025, though it recovered to ₹1.58 Crore in FY2026.
5. Legal Proceedings: There are 9 tax proceedings against the company with an aggregate amount of ₹381.95 Lakhs.

Valuation & Peer Comparison

Valuation multiples such as P/E cannot be calculated as the price band is not available. The company competes in the value and mid-market segments against large FMCG players. Investors will need to wait for the final prospectus to assess valuation relative to peers.

Bottom Line

H R Hygiene Products presents a growth story with improving margins and a strategic move into diaper manufacturing. However, high concentration risks in products, customers, and geography, along with governance concerns regarding multiple auditor changes, require careful due diligence. Investors should monitor the upcoming price band announcement.

H R Hygiene Products Limited (CIN: U74999GJ2016PLC093028), a Gujarat-based manufacturer of hygiene products including sanitary napkins under the Femiss brand, has filed its Draft Red Herring Prospectus (DRHP) with SEBI. The company is planning an SME IPO to fund expansion into diaper manufacturing and repay existing debt. While the exact price band and total issue size are not yet disclosed in the provided data, the identified use of proceeds amounts to ₹34.93 Crores. The IPO is scheduled to open on 29-Jul-2026.

Company Overview

H R Hygiene Products Limited was incorporated in 2016 and is headquartered in Rajkot, Gujarat. The company manufactures hygiene products catering to babies, young women, and the elderly through brands like Femiss, Womanica, ElderFit, and Bloom Baby.

Key operational highlights include:

• Product Focus: Sanitary napkins represent 95.33% of revenue in FY2026.
• Distribution: Pan-India presence across 28 states and 8 union territories via 202 distributors and major e-commerce platforms (Amazon, Flipkart, Meesho).
• Manufacturing: State-of-the-art facility spanning 32,780.88 sq. ft. with ISO 9001:2015, WHO-GMP, BIS, and CE certifications.
• Awards: Femiss Sanitary Pad received the National Award for Excellence in Healthcare 2020.

Offer Details

The company has outlined specific objects for the issue proceeds, though the final price band and lot size remain undisclosed in the current DRHP data.

Objects of Issue

Proceeds will be utilized as follows:

1. New Manufacturing Facility: ₹31.36 Crores for a diaper manufacturing unit (Unit 2) at Rajkot, Gujarat, with an installed capacity of 6 crore pieces annually.
2. Debt Repayment: ₹3.57 Crores for prepayment/repayment of loans.
3. General Corporate Purposes: Unspecified amount for initial development costs and operating expenses.

Total identified use of proceeds: ₹34.93 Crores.

Financial Highlights

The company has demonstrated consistent revenue and profit growth over the last three years. However, investors should note the negative operating cash flow in FY2025.

Balance Sheet & Cash Flow:

• Total Assets grew to ₹170.92 Cr in FY2026 from ₹48.87 Cr in FY2024.
• Operating Cash Flow was negative at -₹10.08 Cr in FY2025 but recovered to ₹1.58 Cr in FY2026.
• Debt-to-Equity ratio stands at 3.03x as of FY2026.

Risk Factors

Investors must consider the following material risks disclosed in the DRHP:

1. Product Concentration: 95.33% of FY2026 revenue came from sanitary napkins.
2. Customer Concentration: Top 10 customers contributed 80.41% of revenue in FY2026, with no long-term contracts.
3. Geographic Concentration: 77.02% of revenue was derived from Gujarat in FY2026.
4. Cash Flow Volatility: Negative operating cash flows of ₹10.08 Cr in FY2025.
5. Legal Proceedings: Outstanding tax proceedings aggregating ₹381.95 Lakhs.
6. Governance Concerns: Multiple changes in statutory auditors, with the latest change in April 2026.

Valuation & Peer Comparison

As the price band is not yet available, precise valuation metrics such as P/E ratio cannot be computed. The company operates in the Indian personal hygiene market, competing with larger FMCG players. Investors should benchmark the eventual issue price against peers in the hygiene sector once the price band is declared.

Bottom Line

H R Hygiene Products presents a growth story with expanding revenue and planned diversification into diapers. However, high concentration risks in product, geography, and customer base, along with governance flags regarding auditor changes, warrant careful scrutiny. The IPO opens on 29-Jul-2026; investors should wait for the price band disclosure before making investment decisions.